Abstract
Oral immunotherapy (OIT) is increasingly gaining acceptance as a food allergy treatment. Treatment success requires adherence to daily dosing and adjustments due to missed doses, illness, or adverse events (AEs). Therefore, treatment teams need timely access to safety and adherence data.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
